ʻO ka Fenofibrate kahi lāʻau lapaʻau hypolipidemic maikaʻi o ka hanauna hou. Hoʻomaopopo ʻia kēia lāʻau lapaʻau no ka mālama ʻana i nā kolamu kiʻekiʻe a me nā triglycerides.
Kele ʻia ka lāʻau lapaʻau i loko o kahi papa ʻaina ma kekahi lāʻau lapaʻau, hiki iā ʻoe ke kūʻai iā ia wale ma ka lāʻau lapaʻau. Hoike ʻia ka hoʻohana ʻana o kahi lāʻau lapaʻau no ka hyperlipidemia maʻamau, i hui ʻia me ka dyslipidemia.
ʻOiai he mau contraindications, he mea nui e nīnau i ke kauka ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau lāʻau. I kēia hihia, ʻaʻole pono kahi e komo i ka lāʻau lapaʻau ponoʻī i pale ai i ke kūkulu ʻana i nā pilikia.
Ke ʻano o ka hana o ka lāʻau
ʻO nā papa lāʻau he lāʻau lipid-e hoʻohaʻahaʻa ana, ka mea me ka fibroic acid.ʻO ka mea ikaika e hoʻonui i ka metabolic kaʻina o ka wehe ʻana i ka lipoproteins atherogen ma lalo o ka hana o ka lipase, hoʻonui i ka manaʻo o ka cholesterol maikaʻi a hoʻēmi i ka neʻe ʻana o ka maikaʻi, a hoʻēmi hoʻi i ka triglycerides.
I ka wā mālama, aia ka emi ʻana o ka protein C-reactive, ka nui o ka fibrinogen a me ka uric acid, kahi hōʻemi i nā tendanth xanthomas. I ka maʻi maʻi, hōʻemi ʻia ke koko koko a me ke ʻano platelet.
Ma hope o ka hoʻomāhao ʻana o ka mea hana i ka micronization, loaʻa iā ia ka bioavailability kiʻekiʻe. No ka hoʻonui i ka absorption, kauoha ʻia ka lāʻau e lawe me nā meaʻai. Inā hoʻohana pinepine ʻia ka lāʻau lapaʻau a no ka manawa lōʻihi, ma muli o ka paʻa mau o ke koko, e lōʻihi ka lōʻihi o ka hopena therapeutic.
- ʻAʻole hōʻiliʻili Fenofibrate a hoʻopili ʻia ma o nā keiki.
- ʻO ka hapalua mau ola he 20 mau hola.
- Hoʻopili piha ke koko i ka lāʻau lapaʻau i ka hebedoma.
Hiki iā ʻoe ke kūʻai i ka lāʻau ma ka mākeke ma ka hōʻike i kahi papa inoa. Loaʻa ka Fenofibrate i ke ʻano o nā papa pihi 145 mg coated.
ʻO ka hui pū ʻana o ka lāʻau lapaʻau ka hopena o ka hana o ka fenofibrate, magnesium stearate, povidone, sodium mannitol croscarmellose, kaʻai kō, ke kai silika.
Fenofibrate: nā ʻōlelo aʻoaʻo no ka hoʻohana a me ke kumukūʻai
Kūkulu ke kauka i ka hoʻohana ʻana i ka lāʻau lapaʻau inā pono ke hoʻokaʻawale i ke kahe o ka triglycerides i ke koko. Me ka atherosclerosis, maʻi mellitus, maʻi maʻi coronary, lawe ʻia ka lāʻau lapaʻau me nā moena a me nā papa ʻē aʻe. Pēlā nō, he lāʻau lapaʻau e kuhikuhi ʻia inā aia he hyperlipidemia kumu.
Hoʻokomo pū ka Fenofibrate i nā ʻōkuhi no ka hoʻohana ʻana, ke kumukūʻai o ka lāʻau lapaʻau, e like me nā loiloi, ʻaʻole iʻoi aʻe ma mua o ke kumukūʻai o nā analogue. Wahi a ka haʻawina, ʻo ka nui loa o ka nui o kēlā me kēia lā he 145 mg. Pio ke papaʻaʻa ʻole me ka huki ʻana i ka wā o kahi pāʻina.
No ka hoʻokō ʻana i kahi hopena therapeutic, lawe ʻia ka lāʻau lapaʻau no ka manawa lōʻihi me ka ʻole ke kaʻawale. Eia kekahi, pono e hahai i ka mea maʻi i kaʻai hypocholesterolemic pololei.
- No ka loiloi i ka ʻike pono o nā lāʻau lapaʻau, pono e hoʻokaʻawale kahi hōʻike koko i ʻekolu mau mahina ma hope o ka hoʻomaka ʻana o ka hoʻomaʻamaʻa. Mālama ʻia kēia mākaukau i kēlā me kēia makahiki.
- Inā hoʻonui ka pae o ka transaminases i ke koko ma mua o ʻekolu mau manawa, pono e oki ʻia ka lāʻau lapaʻau.
- Hoʻohui i ka hoʻohana ʻana o nā papa i pono e haʻalele ʻia inā he nui nā alima o ka manamana phosphokinase i ka manawa ʻelima a aia kekahi hopena hōʻawaʻawa i ka ʻili o nā ʻōhua.
- I ka loaʻaʻana o kahi hopena koʻikoʻi o ka hoʻomohalaʻana i ka maʻi cardiovascular a me kahi maʻi koʻikoʻi o dyslipidemia, kuhikuhi ke kauka i kahi nui o nā stins.
Ke hana ʻia nei ka lāʻau lapaʻau ma lalo o ka mālama mākaʻikaʻi koʻikoʻi. Eia kekahi, pono e ʻike hou ka mea maʻi i kona ola, hoʻoliʻi i ka mea hoʻokūkū hoʻokūkū a hōʻole i ka ʻai ʻana i nā momona momona. Inā ma hope o ʻeono mahina e ʻike ʻia kahi dinamika kūpono, ʻike ʻia kahi hana lapaʻau hou.
Ma mua o ka hoʻomaka ʻana e lawe i nā pōpoki, ua hoʻoholo ʻia ke kumu o ka hoʻonui ʻana o ka cholesterol koko. Inā hoʻokomo ʻia ka pathology ma muli o ka lawe ʻana o kahi kanaka i ka estrogen, pono ʻoe e kāpae i kēia hana i hana maʻamau i nā hōʻailona.
- Ua hoʻohālikelike ʻia ka lāʻau lapaʻau ma ka hihia o ka hypersensitivity, hepatic a me ka maikaʻi ʻole o ka hana ʻana i nā maʻi, nā maʻi o ka gallbladder, nā maʻi a me ka maʻi pancreatitis, ka umauma. Hōʻike ʻia ka mālama ʻana i nā makahiki he 18 o ka makahiki.
- Pono e mālama ʻia inā he hypothyroidism, kahi huaʻāina hoʻoilina no ka maʻi ʻeha, ua hōʻino kekahi kanaka i ka wai ʻula. Hiki i nā wahine hāpai ke hoʻohana i ka fenofibrate wale nō inā ʻaʻohe pilikia o ka pēpē.
E mālama i nā papa i kahi keiki i kahi wahi pōʻeleʻele i ke mahana ma mua o 25 mau kiʻekiʻe. ʻO ʻelua mau makahiki ke ola o ka pale o ka huahana.
Hiki ke kumukūʻai ke kumukūʻai mai 450 a 550 rubles, ma muli o ka hale kūʻai.
Nā hopena hopena
Pono e hāpai ʻia ma ka hopena o ka lāʻau i nā hopena he nui, no laila pono ʻoe e kiʻi pono i nā contraindications. Ma hope o ka lawe ʻana i nā papa, hiki i ka mea maʻi ke hoʻomohala i kahi hopena alakaʻi me ka hōʻeha, ka ʻeha, nā hives a i ʻole ke ʻano photosensitivity, a me ka ulu ʻana o ka creatinine a me urea hiki ke hoʻonui.
Hiki ke hōʻeha ʻia nā hopena ʻino ma ke ʻano o ka ʻeha o ka ʻōpū, ke komo ʻana, ka luaʻi ʻana, ka ʻōpū ʻana o ka ʻōpū, ka lemaki. I nā hihia pinepine, ʻike ʻia ka pancreatitis, nā puka o ka gallstones, a ʻano ʻino loa hoʻi nā maʻi hepatitis. Inā loaʻa i kahi kanaka ka hōʻailona o ka jaundice a hōʻeha paha, pono e hoʻāʻo ʻia ka mea maʻi no ka hepatitis a kāpae i ka lawe ʻana iā Fenofibrate.
ʻO kekahi manawa hōʻike nā hopena hopena i ke ʻano o ka myalgia diffuse, myositis, spasm muscle, nāwaliwali, rhabdomyolysis, hoʻonui i ka hana o ka phosphokinase creatine. Ke hoʻomau nei kekahi poʻe i ka trombosis vein hohonu, pulololi embolism, hoʻonui i ka hemoglobin a me ka helu sela ke keʻokeʻo, ʻeha, a me ka hana hewa. I nā hihia ākea, loaʻa ka maʻi pyropathy interstitial.
ʻAʻole i ʻike ʻia nā hihia overdose, akā inā loaʻa he kānalua no ka hoʻohana pono ʻole i ka lāʻau, ua hōʻike ʻia ka maʻi hōʻailona a me ke kākoʻo kākoʻo. ʻAʻole maikaʻi ka hoʻohana ʻana o ka hemodialysis. ʻAʻole maopopo ka antidotes kikoʻī.
Ke hoʻohana ʻia i ka mālama ʻana i ka paʻakikī a me ka hoʻohana ʻana i nā lāʻau lapaʻau ʻē aʻe, pono e mālama pono.
- Hoʻonui ka Fenofibrate i ka hopena o nā anticoagulants o ka waha, pinepine kēia hopena i ke koko. No laila, ma ka hoʻomaka mua o ka hōʻola, ke hōʻemi ʻia nei ka nui o nā anticoagulants e 1/3. A laila, koho ke kauka i ke kū hoʻokahi i ka maʻi o luna, e ʻohi ana i ke ʻano maʻamau o ka mea maʻi a me ka hopena o nā hōʻike.
- ʻO Cyclosporin, i hoʻohana pū ʻia me ka fenofibrate, e hōʻemi ana i ka hana renal, ma kēia manaʻo, me nā loli koʻikoʻi ma nā ʻāpana lāʻau, a oki ʻia ka therapy. Inā hoʻohana pū ʻia nā lāʻau nephrotoxic, e noʻonoʻo ʻia ka pono a me ke kaʻe, ma hope o ka mea e hoʻoholo ai ka liʻiliʻi ʻokoʻa loa.
- Inā ʻoe e hoʻohui i ka lawe ʻana i ka lāʻau lapaʻau me kahi hui o HMG-CoA reductase inhibitors, acute renal failed, myopathy, rhabdomyolysis hiki ke kūkulu. I ka manawa e ʻike ʻia ai nā ʻōkuhi bile acid, ua emi ka nui o ka hoʻopili ʻana o ka fenofibrate, no laila, lawe ʻia ka papa lipid-kaila i hoʻokahi hola a ʻeono paha ma hope o ka hoʻohana ʻana i kahi lāʻau lapaʻau hou.
Nā hiʻohiʻona o ka lāʻau
Nui kekahi mau lāʻau lapaʻau e loaʻa ai kahi ʻano like. ʻO kēia mau o Trilipix, Exlip, Tsiprofibrat, Lipantil, Tricor tablets. Pēlā pū kekahi i ka mākeke hiki iā ʻoe ke kūʻai i nā lāʻau lapaʻau i ka hopena like ma ke kino - Livostor, Storvas, Tulip, Atorvakor.
Hiki i ka mea maʻi ke koho kūʻokoʻa i kahi lāʻau lapaʻau, kahi i hāʻawi ʻia i ke ʻano a me ke ʻano i kuhikuhi ʻia e ke kauka. Ma ka hoʻoponopono ʻana i nā loiloi, nā papa i hana ʻia ma Iapana, USA, ʻĀkau a me ʻEulopa Hema i manaʻo ʻia he mea e ʻoi loa ia.
No laila, he maikaʻi ka fenofibrate i ka mālamaʻana o hypercholesterolemia i ka type 2 diabetes mellitus. No ka loaʻa o ka hopena wikiwiki a hoʻomaikaʻi hou, lawe ʻia nā statins. Hoʻohana maikaʻi ka lāʻau lapaʻau no ka lāʻau lapaʻau. Hōʻemi nā peni i nā triglycerides, kāpae i ka ulu ʻana o nā hoʻololi kālā, hoʻomaikaʻi i ke ʻano o nā wāwae.
ʻO ka mālama ʻia o ka atherosclerosis i wehewehe ʻia i loko o ke wikiō ma kēia ʻatikala.
